MA29890B1 - Composition a base d'herbes pour les troubles inflammatoires - Google Patents
Composition a base d'herbes pour les troubles inflammatoiresInfo
- Publication number
- MA29890B1 MA29890B1 MA30886A MA30886A MA29890B1 MA 29890 B1 MA29890 B1 MA 29890B1 MA 30886 A MA30886 A MA 30886A MA 30886 A MA30886 A MA 30886A MA 29890 B1 MA29890 B1 MA 29890B1
- Authority
- MA
- Morocco
- Prior art keywords
- compound
- compositions
- relates
- naphtho
- octahydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
Abstract
L'INVENTION CONCERNE UNE COMPOSITION MÉDICINALE COMPRENANT UN EXTRAIT DE FLEUR ET DE FRUIT DE LA PLANTE SPHAERANTHUS INDICUS. L'EXTRAIT DE SPHAERANTHUS INDICUS RENFERME UN COMPOSÉ, 3A-HYDROXY-5A,9-DIMÉTHYL-3- MÉTHYLENE-3A,4,5,5A,6,7,8,9B-OCTAHYDRO-3H-NAPHTHO[1,2-B]FURAN-2-ONE (7- HYDROXY-4,1 1 (13)-EUDESMADIEN-12,6-OLIDE) (COMPOSÉ 1 ) EN TANT QUE MARQUEUR BIOACTIF. L'INVENTION CONCERNE ÉGALEMENT UNE COMPOSITION COMPRENANT 3A-HYDROXY-5A,9-DIMÉTHYL- 3-MÉTHYLENE-3A,4,5,5A,6,7,8,9B-OCTAHYDRO-3H-NAPHTHO[1,2-B]FURAN-2-ONE (COMPOSÉ 1 ) COMME INGRÉDIENT ACTIF. DE PLUS, L'INVENTION ENGLOBE DES MÉTHODES DE FABRICATION DESDITES COMPOSITIONS ET DES MÉTHODES D'ADMINISTRATION À U N SUJET DEVANT ÊTRE TRAITÉ POUR DES TROUBLES INFLAMMATOIRES. L'INVENTION PORTE ÉGALEMENT SUR L'ACTIVITÉ INHIBITRICE DE CES COMPOSITIONS À L'ÉGARD DU FACTEUR $G(A) DE NÉCROSE DES TUMEURS (TNF- A) ET DE L'INTERLEUKINE (IL-1, IL-6, IL-8). ELLE CONCERNE EN OUTRE L'INHIBITION PAR LESDITS COMPOSITIONS DE L'EXPRESSION DE LA MOLÉCULE 1 D'ADHÉSION INTERCELLULAIRE (ICAM-1 ), DE LA MOLÉCULE 1 D'ADHÉSION DES CELLULES VASCULAIRES (VCAM-1 ) ET DE LA SÉLECTINE E. CES COMPOSTIONS PEUVENT ÉVENTUELLEMENT CONTENIR AU MOINS UN AGENT ANTI-INFLAMMATOIRE OU PEUVENT ÊTRE UTILISÉES EN ASSOCIATION AVEC AU MOINS UN AGENT ANTI-INFLAMMATOIRE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1226MU2005 | 2005-09-30 | ||
US73644305P | 2005-11-14 | 2005-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29890B1 true MA29890B1 (fr) | 2008-10-03 |
Family
ID=37900158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30886A MA29890B1 (fr) | 2005-09-30 | 2008-04-29 | Composition a base d'herbes pour les troubles inflammatoires |
Country Status (11)
Country | Link |
---|---|
US (2) | US7635494B2 (fr) |
EP (1) | EP1931366B1 (fr) |
JP (1) | JP5331962B2 (fr) |
AU (1) | AU2006296197B2 (fr) |
CA (1) | CA2624049C (fr) |
EA (1) | EA014070B1 (fr) |
GE (1) | GEP20115332B (fr) |
HK (1) | HK1112418A1 (fr) |
MA (1) | MA29890B1 (fr) |
PL (1) | PL1931366T3 (fr) |
WO (1) | WO2007036900A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8981131B2 (en) * | 2007-07-27 | 2015-03-17 | Piramal Enterprises Limited | Tricyclic compounds for the treatment of inflammatory disorders |
US8383166B2 (en) * | 2007-12-03 | 2013-02-26 | Sequent Scientific Limited | Stable hydrophobic topical herbal formulationn |
KR101682489B1 (ko) * | 2009-02-02 | 2016-12-05 | 라일라 뉴트라슈티칼스 | 대사성 증후군의 조절을 위한 스파란터스 인디커스 및 가르시니아 망고스타나 유래의 조성물 |
WO2012014216A1 (fr) * | 2010-07-28 | 2012-02-02 | Laila Nutraceuticals | 7-hydroxyfrullanolide et ses analogues pour la prévention, la maîtrise et le traitement de troubles du métabolisme. |
US10105347B2 (en) | 2009-02-02 | 2018-10-23 | Laila Nutraceuticals | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels |
WO2011033524A2 (fr) * | 2009-08-04 | 2011-03-24 | Laila Nutraceuticals | Agents dérivés de ficus hispida pour l'amélioration du syndrome métabolique et de maladies associées |
WO2011083397A1 (fr) * | 2010-01-05 | 2011-07-14 | Himalaya Global Holdings Limited | Composition phytothérapeutique pour les troubles de la peau |
CN103108556A (zh) * | 2010-09-11 | 2013-05-15 | 莱拉营养食品有限公司 | 绒毛戴星草衍生成分 |
US8263579B2 (en) * | 2011-01-24 | 2012-09-11 | Piramal Healthcare Limited | Anti-inflammatory compounds |
JP2015535236A (ja) * | 2012-10-23 | 2015-12-10 | ピラマル・エンタープライゼズ・リミテッドPiramal Enterprises Limited | TNF−α媒介性疾患の予防および処置のための薬草組成物 |
EP3313384A4 (fr) | 2015-06-23 | 2019-04-03 | Nobilis Therapeutics, Inc. | Modulation immunitaire thérapeutique à l'aide de compositions de gaz noble |
CA3023426A1 (fr) * | 2016-05-21 | 2017-11-30 | Laila Impex | Complements alimentaires et compositions permettant d'ameliorer les performances physiques et les niveaux d'energie |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646687A (en) * | 1994-12-29 | 1997-07-08 | Lucent Technologies Inc. | Temporally-pipelined predictive encoder/decoder circuit and method |
US6204523B1 (en) * | 1998-11-06 | 2001-03-20 | Lumileds Lighting, U.S., Llc | High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range |
US6686676B2 (en) * | 2001-04-30 | 2004-02-03 | General Electric Company | UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same |
US6989412B2 (en) * | 2001-06-06 | 2006-01-24 | Henkel Corporation | Epoxy molding compounds containing phosphor and process for preparing such compositions |
US6841647B2 (en) * | 2001-11-06 | 2005-01-11 | National Starch And Chemical Investment Holding Corporation | Fluid resistant silicone encapsulant |
US7160972B2 (en) * | 2003-02-19 | 2007-01-09 | Nusil Technology Llc | Optically clear high temperature resistant silicone polymers of high refractive index |
US7261441B2 (en) * | 2004-02-27 | 2007-08-28 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | LED device and method for directing LED light |
WO2006016228A2 (fr) * | 2004-08-02 | 2006-02-16 | Prashanth Kumar V | Alkaloide peptide cytotoxique et compositions pharmaceutiques pour le traitement des maladies neoplastiques |
US7229934B2 (en) * | 2004-10-18 | 2007-06-12 | International Business Machines Corporation | Porous organosilicates with improved mechanical properties |
-
2006
- 2006-09-28 CA CA2624049A patent/CA2624049C/fr active Active
- 2006-09-28 WO PCT/IB2006/053540 patent/WO2007036900A2/fr active Application Filing
- 2006-09-28 AU AU2006296197A patent/AU2006296197B2/en not_active Ceased
- 2006-09-28 EP EP06809434.1A patent/EP1931366B1/fr active Active
- 2006-09-28 GE GEAP200610647A patent/GEP20115332B/en unknown
- 2006-09-28 JP JP2008532961A patent/JP5331962B2/ja not_active Expired - Fee Related
- 2006-09-28 PL PL06809434T patent/PL1931366T3/pl unknown
- 2006-09-28 EA EA200800850A patent/EA014070B1/ru active IP Right Revival
-
2008
- 2008-03-28 US US12/079,853 patent/US7635494B2/en active Active
- 2008-04-29 MA MA30886A patent/MA29890B1/fr unknown
- 2008-07-16 HK HK08107874.8A patent/HK1112418A1/xx not_active IP Right Cessation
-
2009
- 2009-07-09 US US12/500,057 patent/US8206756B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EA014070B1 (ru) | 2010-08-30 |
JP5331962B2 (ja) | 2013-10-30 |
EP1931366B1 (fr) | 2013-05-29 |
JP2009510051A (ja) | 2009-03-12 |
CA2624049A1 (fr) | 2007-04-05 |
US20080254157A1 (en) | 2008-10-16 |
HK1112418A1 (en) | 2008-09-05 |
WO2007036900A2 (fr) | 2007-04-05 |
GEP20115332B (en) | 2011-11-25 |
PL1931366T3 (pl) | 2013-11-29 |
EP1931366A2 (fr) | 2008-06-18 |
US20090269427A1 (en) | 2009-10-29 |
US7635494B2 (en) | 2009-12-22 |
AU2006296197B2 (en) | 2012-08-09 |
US8206756B2 (en) | 2012-06-26 |
EA200800850A1 (ru) | 2008-10-30 |
CA2624049C (fr) | 2016-01-12 |
WO2007036900A3 (fr) | 2007-08-02 |
AU2006296197A1 (en) | 2007-04-05 |
AU2006296197A2 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29890B1 (fr) | Composition a base d'herbes pour les troubles inflammatoires | |
NL350084I2 (nl) | Sedaxaan en Fludioxonil | |
MA30342B1 (fr) | Nouvelles compositions pour des troubles capillaires et procede de preparation de celles-ci | |
EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
ATE459357T1 (de) | Kombinationen zur behandlung von multiplem myelom | |
MA31743B1 (fr) | Traitement apres recolte | |
FR2393531A1 (fr) | Compositions fongicides pour l'agriculture a base de derives de 4-aminoquinazoline | |
BR0312232A (pt) | Inibidores de caspases e seus usos | |
Bitasta et al. | Aerva lanata: A blessing of mother nature | |
ES2426174T8 (es) | Composición herbácea para trastornos inflamatorios | |
KR100371858B1 (en) | Antimicrobial composition containing plant extract | |
Banisalam et al. | Comparison between in vitro and in vivo antibacterial activity of Curcuma zedoaria from Malaysia | |
CO5280139A1 (es) | Procedimiento para obtener plantas con un mayor contenido de flavonoides y compuestos fenolicos | |
CA2439430A1 (fr) | Extrait d'agastache rugosa et composition renfermant de la tilian ine isolee et purifiee a partir dudit extrait dote d'une activite anti-inflammatoire et activite anti-atherogene | |
WO2023069514A3 (fr) | Composés bifonctionnels pour la dégradation de l'itk par l'intermédiaire d'une voie de l'ubiquitine protéosome | |
WO2007042983A3 (fr) | Utilisation de fluridone comme agent anti-inflammatoire | |
Mohamed et al. | Promising selective MAO-B inhibition by sesamin, a lignan from Zanthoxylum flavum stems | |
Kulkarni | Anti-inflammatory activity of Vitex trifolia Linn.(verbaneaceae) leaves extracts | |
Kavyashree et al. | A review on Tulasi (Ocimum sanctum Linn.) | |
Velayutham et al. | A Concise Review on Phytochemical and Pharmacological Studies of Hybanthus enneaspermus (L.) F. Muell | |
Venugopal et al. | Cocos nucifera: It’s pharmacological activities | |
Venkateswaran et al. | Evaluation of Antihyperlipidemic Activity of Ethanolic Root Extract of Carica Papaya in Poloxamer—407 Induced Hyperlipidemia in Wistar Rats | |
Bhattacharya et al. | In vitro regeneration of some lesser known medicinal Zingibers: a review | |
Erjaee et al. | Evaluation of the Anti-inflammatory and Antioxidant Parameters of Aqueous and Ethanolic Extracts of Roman chamomile in mice | |
Mohebbati et al. | Hypotensive Effect of Hydroalcoholic Ziziphus jujuba Extract on Normotensive Rats |